Sparfloxacin Production Cost Reports

The report provides a detailed analysis essential for establishing a Sparfloxacin production plant. It encompasses all critical aspects necessary for Sparfloxacin production, including the cost of Sparfloxacin production, Sparfloxacin plant cost, Sparfloxacin production costs, and the overall Sparfloxacin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Sparfloxacin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Sparfloxacin is an antibiotic from the fluoroquinolone family that works by stopping harmful bacteria from copying their DNA.  This kills them and helps fight off infections without harming the body. It is used for serious lung problems like community-acquired pneumonia. It helps in treating germs like Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Mycoplasma or Chlamydia.

It is also used for flare-ups of chronic bronchitis, where bacteria make coughing and breathing worse. It treats other common infections like those in the urinary tract, sinuses, tonsils and throat, skin and soft tissues, and even female genital infections. Its common side effects are diarrhoea, nausea, vomiting, headache, dizziness, rash, abdominal pain, dry mouth, insomnia, changes in taste, photosensitivity, and indigestion.

The market for Sparfloxacin is driven by the growing cases of bacterial infections. Its usage in respiratory conditions like community-acquired pneumonia, chronic bronchitis exacerbations, sinusitis, and COPD flares contributes to its market growth. The rising demand for effective broad-spectrum fluoroquinolone antibiotics in regions with high infection and expanding healthcare infrastructure, with increased awareness of timely antibiotic therapy, fuels its demand.

The industrial Sparfloxacin procurement is influenced by generic competition from numerous low-cost manufacturers, which leads to highly competitive pricing and easy availability that favours. The regulatory pressures for high API purity to meet FDA and EMA standards, because of antibiotic resistance concerns, affect sourcing. Also, raw material shortages and GMP compliance for APIs and preference for proven safety-efficacy profiles over alternatives impact its market dynamics.

Raw Material for Sparfloxacin Production

According to the Sparfloxacin production plant project report, the key raw materials used in the production of Sparfloxacin include Ethyl Pentafluoro benzoylacetate and Ethyl Orthoformate.

Production Process of Sparfloxacin

The extensive Sparfloxacin production cost report consists of the following major industrial production process:

• From Ethyl Pentafluoro benzoylacetate and Ethyl Orthoformate: The production process of Sparfloxacin involves several steps. The process starts from ethyl pentafluoro benzoylacetate, which reacts with ethyl orthoformate in refluxing acetic anhydride, followed by cyclopropylamine in ether to form the aminomethylene derivative. This is then cyclized using NaH in THF to yield ethyl 5,6,7,8-tetrafluoro-1-cyclopropyl-4-oxo-1,4-dihydroquinoline-3-carboxylate. This intermediate is next treated with benzylamine and potassium carbonate in refluxing acetonitrile to introduce the benzylamino group, followed by hydrogenolytic deprotection to form ethyl 5-amino-1-cyclopropyl-6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate. This goes through hydrolysis and condensation to get Sparfloxacin as the final product.

Sparfloxacin has the molecular formula of C19H22F2N4O3 and a molecular weight of 392.4 g/mol. It has an XLogP3 value of 0.1, indicating low lipophilicity. It has 3 hydrogen bond donors, 9 acceptors, 3 rotatable bonds, and a topological polar surface area of 98.9 Ų. It is classified within quinoline carboxylic acids and appears as a yellow crystalline powder or off-white to yellow crystals. It has a melting point of around 265-268 degree Celsius with decomposition and shows insolubility in water. It binds 37-45% to plasma proteins, exhibits good tissue penetration, and has collision cross sections. All these physical and chemical properties contribute to its antibacterial activity via DNA gyrase inhibition.